COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 269: Articles 2681-2690  | Next

Global patterns of rebound to normal RSV dynamics following COVID-19 suppression
Thindwa, D., Li, K., Cooper-Wootton, D., Zheng, Z., Pitzer, V. E., Weinberger, D. M.
10.1101/2024.02.23.24303265 — Posted: 2024-02-24
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial
HITES, M., MASSONNAUD, C. R., JAMARD, S., Goehringer, F., DANION, F., REIGNIER, J., DE CASTRO, N., GAROT, D., LARRANAGA LAPIQUE, E., LACOMBE, K., TOLSMA, V., FAURE, E., MALVY, D., STAUB, T., COURJON, J., CAZENAVE-ROBLOT, F., DYRHOL RIISE, A. M., LE TURNIER, P., MARTIN BLONDEL, G., ROGER, C., AKINOSOGLOU, K., LE MOING, V., PIROTH, L., SELLIER, P., LESCURE, X., TROSEID, M., CLEVENBERGH, P., DALGARD, O., GALLIEN, S., GOUSSEFF, M., LOUBET, P., BOUNES - VARDON, F., VISEE, C., BELKHIR, L., BOTELHO-NEVERS, E., CABIE, A., KOTANIDOU, A., LANTERNIER, F., ROUVEIX-NORDON, E., SILVA, S., THIERY, G., POIGNA
10.1101/2024.02.23.24302586 — Posted: 2024-02-24
Changes in opioid prescribing during the COVID-19 pandemic in England: cohort study of 20 million patients in OpenSAFELY-TPP
Schaffer, A. L., Andrews, C. D., Brown, A. D., Croker, R., Hulme, W. J., Nab, L., Quinlan, J., Speed, V., Wood, C., Wiedemann, M., Massey, J., Inglesby, P., Bacon, S. C., Mehrkar, A., Bates, C., Goldacre, B., The OpenSAFELY Collaborative, , Walker, A. J., MacKenna, B.
10.1101/2024.02.23.24303238 — Posted: 2024-02-24
A Population-Based Cross-Sectional Investigation of COVID-19 Hospitalizations and Mortality Among Autistic People
Nijhof, D., Sosenko, F., MacKay, D., Fleming, M., Jani, B. D., Pell, J., Hatton, C., Cairns, D., Henderson, A., Ward, L. M., Rydzewska, E., Gardani, M., Millington, E., Melville, C.
10.1101/2024.02.23.24303274 — Posted: 2024-02-24
Prospective study of machine learning for identification of high-risk COVID-19 patients
Frausto-Avila, C. M., Leon-Montiel, R. d. J., Quiroz-Juarez, M. A., U'Ren, A. B.
10.1101/2024.02.21.24303159 — Posted: 2024-02-23
Thrombotic and thromboembolic events, with or without thrombocytopenia, following viral vector-based COVID-19 vaccines administration: a systematic review protocol.
Ramos-Rojas, J., Pena, J., Pinto-Diaz, C., Veloso, V., Rada, G., Molina-Leon, H. F.
10.1101/2024.02.22.24303207 — Posted: 2024-02-23
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant
Chemaitelly, H., Coyle, P., Kacem, M. A. B., Ayoub, H., Tang, P., Hasan, M. R., YASSINE, H. M., Althani, A., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2024.02.22.24303193 — Posted: 2024-02-23
Modeling the relative influence of socio-demographic variables on post-acute COVID-19 quality of life: an application to settings in Europe, Asia, Africa, and South America
Menkir, T. F., Citarella, B., Sigfrid, L., Doshi, Y., Reyes, L. F., Calvache, J. A., Kildal, A. B., Nygaard, A. B., Holter, J. C., Panda, P. K., Jassat, W., Merson, L., Donnelly, C. A., Santillana, M., Buckee, C., Verguet, S., Hejazi, N. S.
10.1101/2024.02.21.24303099 — Posted: 2024-02-23
Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution
Pisanic, N., Antar, A. A., Hetrich, M. K., Demko, Z. O., Zhang, X., Spicer, K., Kruczynski, K. L., Detrich, B., Knoll, M. D., Thomas, D. L., Dawood, F. S., Veguilla, V., Karron, R. A., Manabe, Y. C., Heaney, C. D.
10.1101/2024.02.21.24303146 — Posted: 2024-02-23
A specific phosphorylation-dependent conformational switch of SARS-CoV-2 nucleoprotein inhibits RNA binding
Botova, M., Camacho-Zarco, A. R., Tognetti, J., Bessa, L. M., Guseva, S., Mikkola, E., Salvi, N., Maurin, D., Herrmann, T., Blackledge, M.
10.1101/2024.02.22.579423 — Posted: 2024-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).